| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-96 |
| filingDate |
1999-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc64855f3a03f8d1ede00801df3588d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3266b0f3f6d09ddb2b01f7fedace52bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_330d2b5412a69caffcd3ccfaf8c902f3 |
| publicationDate |
2001-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001114689-A |
| titleOfInvention |
Tyrosine phosphatase inhibitor |
| abstract |
PROBLEM TO BE SOLVED: To provide a drug having a novel mechanism of action, which is involved in activation of T cells and mast cells involved in immunity and allergic reactions and inhibits tyrosine phosphatase possessed by CD45 antigen. SOLUTION: The formula: (Wherein R 1 and R 2 are the same or different and each is a phenyl group, X represents a phenyl group or a naphthyl group substituted with 1 to 3 halogen atoms, and X represents an oxygen atom or an imino group. A tyrosine phosphatase inhibitor comprising the compound represented by the formula (1) as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4656787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003104964-A |
| priorityDate |
1999-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |